Welcome Guest!  Login | Register | Help
Home News Screener Maps Groups Portfolio Insider Futures Forex Collaborate Store Elite
Settings
FLDM [NASD]
Fluidigm Corporation
Index- P/E- EPS (ttm)-1.38 Insider Own11.35% Shs Outstand28.17M Perf Week-15.17%
Market Cap741.72M Forward P/E- EPS next Y-1.42 Insider Trans-0.03% Shs Float27.72M Perf Month-6.13%
Income-37.00M PEG- EPS next Q-0.47 Inst Own95.30% Short Float7.69% Perf Quarter-7.97%
Sales92.50M P/S8.02 EPS this Y24.40% Inst Trans2.03% Short Ratio6.99 Perf Half Y-44.60%
Book/sh5.79 P/B4.55 EPS next Y28.60% ROA-13.80% Target Price45.83 Perf Year13.20%
Cash/sh3.37 P/C7.82 EPS next 5Y33.00% ROE-28.30% 52W Range21.41 - 49.46 Perf YTD-31.22%
Dividend- P/FCF- EPS past 5Y48.40% ROI-19.40% 52W High-46.77% Beta0.93
Dividend %- Quick Ratio4.10 Sales past 5Y36.00% Gross Margin67.90% 52W Low22.98% ATR1.15
Employees325 Current Ratio4.70 Sales Q/Q57.70% Oper. Margin-28.80% RSI (14)37.37 Volatility4.94% 4.28%
OptionableYes Debt/Eq1.21 EPS Q/Q-181.30% Profit Margin-40.00% Rel Volume1.18 Prev Close28.10
ShortableYes LT Debt/Eq1.21 EarningsJul 31 AMC Payout- Avg Volume305.34K Price26.33
Recom2.00 SMA20-7.14% SMA50-6.84% SMA200-24.68% Volume361,085 Change-6.30%
06-May-14Reiterated Maxim Group Buy $65 → $52
23-Apr-14Upgrade Mizuho Neutral → Buy $43 → $50
21-Mar-14Reiterated Maxim Group Buy $52 → $65
03-Feb-14Reiterated Oppenheimer Outperform $46 → $52
14-Jan-14Reiterated Mizuho Neutral $30 → $43
18-Dec-13Reiterated Maxim Group Buy $33 → $42
31-Oct-13Reiterated Mizuho Neutral $19 → $30
31-Oct-13Reiterated Maxim Group Buy $26 → $33
02-Aug-13Reiterated Mizuho Neutral $17 → $19
02-Aug-13Reiterated Maxim Group Buy $21 → $23
27-Jun-13Initiated Maxim Group Buy $21
09-Oct-12Downgrade Mizuho Buy → Neutral $17
31-Aug-12Initiated Mizuho Buy $17
27-Jun-12Initiated Cantor Fitzgerald Buy $17
15-Feb-12Reiterated Deutsche Bank Buy $16 → $19.50
05-Oct-11Initiated Oppenheimer Outperform $19
23-Mar-11Initiated Deutsche Bank Buy $19
19-Sep-14 07:07AM  FLUIDIGM CORP Files SEC form 8-K, Entry into a Material Definitive Agreement EDGAR Online -6.30%
16-Sep-14 04:00PM  Fluidigms New JunoTM System Shatters Barriers For SNP Genotyping Business Wire
03-Sep-14 07:28AM  Fluidigm Corp. (FLDM) Worth Watching: Stock Up 5.1% Zacks
02-Sep-14 01:00PM  Fluidigm to Present at the Morgan Stanley Global Healthcare Conference Business Wire +5.07%
09-Aug-14 01:04PM  FLUIDIGM CORP Financials EDGAR Online Financials
06-Aug-14 09:00AM  UCSF/Fluidigm Paper Proves Shallow Sequencing of Related Single Cells Sufficient to Harvest Meaningful Biological Information Business Wire
04-Aug-14 03:57PM  FLUIDIGM CORP Files SEC form 10-Q, Quarterly Report EDGAR Online
31-Jul-14 04:17PM  FLUIDIGM CORP Files SEC form 8-K, Results of Operations and Financial Condition, Financial Statements and Exhibits EDGAR Online
04:05PM  Fluidigm Reports Q2 2014 Results Business Wire
04:00PM  Fluidigm Announces Early Access Program for New Imaging Mass Cytometry Platform Business Wire
07:07AM  Q2 2014 Fluidigm Corp Earnings Release - After Market Close CCBN
23-Jul-14 09:00AM  Fluidigm to Announce Q2 2014 Financial Results and Host Conference Call for Investors Business Wire +5.08%
10-Jul-14 10:59AM  Fluidigm expected to report strong quarter at Piper Jaffray theflyonthewall.com
30-Jun-14 09:00AM  Single-Cell mRNA Sequencing Helps Reveal the Role of Precocious Dendritic Cells in Inflammatory Response Business Wire
19-Jun-14 09:00AM  Fluidigm Accelerates Single-Cell Science with the New C1 Open App Program Business Wire
09:00AM  Fluidigm Accelerates Single-Cell Science with the New C1 Open App Program
10-Jun-14 04:00PM  FLUIDIGM CORP Files SEC form 8-K, Entry into a Material Definitive Agreement EDGAR Online
04:00PM  FLUIDIGM CORP Files SEC form 8-K, Entry into a Material Definitive Agreement
03-Jun-14 09:00AM  Fluidigm Ships FLEXsixTM Integrated Fluidic Circuits to Genotyping and Gene Expression Customers Business Wire
09:00AM  Fluidigm Ships FLEXsixTM Integrated Fluidic Circuits to Genotyping and Gene Expression Customers
28-May-14 04:13PM  FLUIDIGM CORP Files SEC form 8-K, Submission of Matters to a Vote of Security Holders EDGAR Online
04:13PM  FLUIDIGM CORP Files SEC form 8-K, Submission of Matters to a Vote of Security Holders
20-May-14 01:04PM  FLUIDIGM CORP Financials EDGAR Online Financials
01:04PM  FLUIDIGM CORP Financials
12-May-14 05:07PM  FLUIDIGM CORP Files SEC form 10-Q, Quarterly Report EDGAR Online
05:07PM  FLUIDIGM CORP Files SEC form 10-Q, Quarterly Report
06-May-14 09:00AM  Fluidigm to Present at the Bank of America Merrill Lynch 2014 Healthcare Conference Business Wire -16.06%
09:00AM  Fluidigm to Present at the Bank of America Merrill Lynch 2014 Healthcare Conference
05-May-14 11:22PM  Fluidigm's (FLDM) CEO Gajus Worthington on Q1 2014 Results - Earnings Call Transcript at Seeking Alpha
11:22PM  Fluidigm's (FLDM) CEO Gajus Worthington on Q1 2014 Results - Earnings Call Transcript
04:55PM  Fluidigm Corporation Discusses Q1 2014 Results (Webcast) at Seeking Alpha
04:55PM  Fluidigm Corporation Discusses Q1 2014 Results (Webcast)
04:49PM  FLUIDIGM CORP Files SEC form 8-K, Results of Operations and Financial Condition, Financial Statements and Exhibits EDGAR Online
04:49PM  FLUIDIGM CORP Files SEC form 8-K, Results of Operations and Financial Condition, Financial Statements and Exhibits
04:26PM  Fluidigm Reports Q1 2014 Results Business Wire
07:07AM  Q1 2014 Fluidigm Corp Earnings Release - After Market Close CCBN
29-Apr-14 10:49AM  Fluidigm: Unique Investing Opportunity In Single-Cell Genomics at Seeking Alpha
23-Apr-14 08:00PM  Fluidigm to Announce Q1 2014 Financial Results and Host Conference Call for Investors Business Wire
05:48AM  Fluidigm upgraded by Mizuho Briefing.com
14-Apr-14 12:02PM  Why Fluidigm (FLDM) Stock Is Up Today at TheStreet
07:04AM  Fluidigm upgraded to Outperform from Market Perform at Leerink theflyonthewall.com
09-Apr-14 07:56AM  Fluidigm (FLDM) is now in Oversold Territory Zacks
08-Apr-14 01:33PM  Analyst Bullish On Medical Research, Equipment Stocks at Investor's Business Daily
18-Mar-14 01:04PM  FLUIDIGM CORP Financials EDGAR Online Financials
12-Mar-14 05:01PM  FLUIDIGM CORP Files SEC form 10-K, Annual Report EDGAR Online
10-Mar-14 05:00PM  FLUIDIGM CORP Files SEC form 8-K, Change in Directors or Principal Officers EDGAR Online
05-Mar-14 04:28PM  FLUIDIGM CORP Files SEC form 8-K, Termination of a Material Definitive Agreement EDGAR Online
28-Feb-14 10:23AM  Bryan Brokmeier Remains Bullish On Life Sciences Tools And Diagnostics Companies at Seeking Alpha
26-Feb-14 09:00AM  Fluidigm to Present at the Cowen and Company 34th Annual Health Care Conference Business Wire
09:00AM  Fluidigm to Present at the Cowen and Company 34th Annual Health Care Conference
14-Feb-14 05:22PM  FLUIDIGM CORP Files SEC form 8-K, Results of Operations and Financial Condition, Change in Directors or Principal Off EDGAR Online
06:04AM  FLUIDIGM CORP Files SEC form 8-K, Completion of Acquisition or Disposition of Assets, Unregistered Sale of Equity Sec EDGAR Online
13-Feb-14 04:30PM  Fluidigm Completes Acquisition of DVS Sciences Business Wire
04:30PM  Fluidigm Completes Acquisition of DVS Sciences
10-Feb-14 05:54AM  Fluidigm Corporation (FLDM) Crumbles: Stock Falls by 6.4% Zacks
05:54AM  Fluidigm Corporation (FLDM) Crumbles: Stock Falls by 6.4%
05:54AM  Fluidigm Corporation (FLDM) Crumbles: Stock Falls by 6.4% Zacks
05:54AM  Fluidigm Corporation (FLDM) Crumbles: Stock Falls by 6.4%
05:54AM  Fluidigm Corporation (FLDM) Crumbles: Stock Falls by 6.4% Zacks
05:54AM  Fluidigm Corporation (FLDM) Crumbles: Stock Falls by 6.4%
05:50AM  Fluidigm Corporation (FLDM) Crumbles: Stock Falls by 6.4% Zacks
05:50AM  Fluidigm Corporation (FLDM) Crumbles: Stock Falls by 6.4%
07-Feb-14 07:51AM  Fluidigm downgraded at Cowen at theflyonthewall.com -6.43%
12:54AM  Fluidigm's CEO Discusses Q4 2013 Results - Earnings Call Transcript at Seeking Alpha
06-Feb-14 04:55PM  Q4 2013 Fluidigm Corp Earnings Conference call (Webcast) at Seeking Alpha
04:24PM  FLUIDIGM CORP Files SEC form 8-K, Results of Operations and Financial Condition, Financial Statements and Exhibits EDGAR Online
04:00PM  Fluidigm Reports Strong Revenue for Q4 and the Full Year 2013 Business Wire
10:30AM  Insider Trading Alert - CMA, FLDM, CNQR, MFRM And AWAY Traded By Insiders at TheStreet
07:07AM  Q4 2013 Fluidigm Corp Earnings Release - After Market Close CCBN
04-Feb-14 04:13PM  FLUIDIGM CORP Files SEC form 8-K, Entry into a Material Definitive Agreement, Creation of a Direct Financial Obligati EDGAR Online
03-Feb-14 07:35AM  Fluidigm acquisition positive, says Oppenheimer theflyonthewall.com
07:35AM  Fluidigm acquisition positive, says Oppenheimer
31-Jan-14 06:30PM  Fluidigm to Announce Q4/Full Year 2013 Financial Results and Host Conference Call for Investors Business Wire
06:30PM  Fluidigm to Announce Q4/Full Year 2013 Financial Results and Host Conference Call for Investors
30-Jan-14 01:32PM  FLUIDIGM CORP Files SEC form 8-K, Entry into a Material Definitive Agreement, Financial Statements and Exhibits EDGAR Online +11.56%
01:32PM  FLUIDIGM CORP Files SEC form 8-K, Entry into a Material Definitive Agreement, Financial Statements and Exhibits
08:00AM  Fluidigm Announces Pricing of $175 Million Convertible Senior Notes Offering Business Wire
08:00AM  Fluidigm Announces Pricing of $175 Million Convertible Senior Notes Offering
07:01AM  Fluidigm price target raised to $47 from $28 at Cantor theflyonthewall.com
07:01AM  Fluidigm price target raised to $47 from $28 at Cantor
29-Jan-14 08:35AM  Fluidigm announces proposed $175M convertible notes offering at theflyonthewall.com
08:35AM  Fluidigm announces proposed $175M convertible notes offering
08:31AM  Fluidigm Announces Proposed $175 Million Convertible Senior Notes Offering Business Wire
08:31AM  Fluidigm Announces Proposed $175 Million Convertible Senior Notes Offering
07:13AM  FLUIDIGM CORP Files SEC form 8-K, Entry into a Material Definitive Agreement, Unregistered Sale of Equity Securities, EDGAR Online
07:13AM  FLUIDIGM CORP Files SEC form 8-K, Entry into a Material Definitive Agreement, Unregistered Sale of Equity Securities,
07:00AM  Fluidigm and DVS Sciences Announce Agreement for Fluidigm to Acquire DVS Sciences Creating a Single-Cell Technology Powerhouse Business Wire
07:00AM  Fluidigm and DVS Sciences Announce Agreement for Fluidigm to Acquire DVS Sciences Creating a Single-Cell Technology Powerhouse
23-Jan-14 12:51PM  [video] Wildly bullish on American capitalism: Pro at CNBC
12:51PM  [video] Wildly bullish on American capitalism: Pro
16-Jan-14 11:49AM  Commit To Purchase Fluidigm At $35, Earn 19.8% Annualized Using Options at TheStreet
11:49AM  Commit To Purchase Fluidigm At $35, Earn 19.8% Annualized Using Options
15-Jan-14 04:41PM  Fluidigm Jumps on Guidance Boost Zacks
04:41PM  Fluidigm Jumps on Guidance Boost
14-Jan-14 12:50PM  FLUIDIGM CORP Files SEC form 8-K, Results of Operations and Financial Condition, Financial Statements and Exhibits EDGAR Online +7.24%
12:50PM  FLUIDIGM CORP Files SEC form 8-K, Results of Operations and Financial Condition, Financial Statements and Exhibits
09:00AM  Fluidigm Announces Preliminary Fourth Quarter 2013 Revenue and Issues 2014 Revenue Guidance Business Wire
09:00AM  Fluidigm Announces Preliminary Fourth Quarter 2013 Revenue and Issues 2014 Revenue Guidance
09-Jan-14 05:12AM  Fluidigm: 4 Different Insiders Have Sold Shares During The Last 30 Days at Seeking Alpha
05:12AM  Fluidigm: 4 Different Insiders Have Sold Shares During The Last 30 Days
Fluidigm Corporation develops, manufactures, and sells microfluidic systems worldwide. It offers BioMark HD System that performs high-throughput and single-cell targeted gene expression analysis, single nucleotide polymorphism (SNP) genotyping, and digital polymerase chain reaction (PCR) using Fluidigm DELTAgene and SNPtype assays, other chemistries, and Fluidigm Dynamic Array and Digital Array integrated fluidic circuits (IFCs). The company also provides C1 Single-Cell Auto Prep System, which enables the isolation, processing, and profiling of individual cells for genomic analysis for applications comprising single-cell targeted gene expression, single-cell micro ribonucleic acid (RNA) analysis, single-cell messenger RNA analysis, and single-cell targeted DNA sequencing using the company's C1 Single-Cell Auto Prep Array IFCs and C1 reagent kit. In addition, it offers EP1 System, which performs SNP genotyping using Fluidigm SNPtype assays or TagMan assays, as well as end-point digital PCR using TaqMan assays, and Fluidigm Dynamic Array and Digital Array IFCs; and Access Array System to enable PCR-based target enrichment, barcoding, and the tagging of targeted resequencing libraries. Further, the company provides Dynamic Array, Digital Array, C1 Single-Cell Auto Prep Array, and Access Array IFCs; DELTAgene and SNPtype assays; and Access Array Target-Specific primers. It serves academic institutions; clinical laboratories; and pharmaceutical, biotechnology, and agricultural biotechnology companies in single-cell genomics, applied genotyping, and sample preparation for targeted re sequencing markets. Fluidigm Corporation distributes its products through support organizations, distributors, or sales agents, as well as through its direct sales force. The company was formerly known as Mycometrix Corporation and changed its name to Fluidigm Corporation in April 2001. Fluidigm Corporation was founded in 1999 and is headquartered in South San Francisco, California.
Insider Trading Relationship Date Transaction Cost #Shares Value ($) #Shares Total SEC Form 4
Smith William MaxwellEVP, LEGAL AFFAIRS & GCSep 15Option Exercise4.453,00013,3383,508Sep 17 06:38 PM
Smith William MaxwellEVP, LEGAL AFFAIRS & GCSep 15Sale30.833,00092,490508Sep 17 06:38 PM
JOG VIKRAMCHIEF FINANCIAL OFFICERSep 08Option Exercise16.733,95066,0844,458Sep 10 07:56 PM
JOG VIKRAMCHIEF FINANCIAL OFFICERSep 08Sale28.573,950112,852508Sep 10 07:56 PM
Smith William MaxwellEVP, LEGAL AFFAIRS & GCAug 15Option Exercise3.413,00010,2293,290Aug 19 06:54 PM
Smith William MaxwellEVP, LEGAL AFFAIRS & GCAug 15Sale27.853,00083,550290Aug 19 06:54 PM
JOG VIKRAMCHIEF FINANCIAL OFFICERAug 07Option Exercise15.643,73358,3764,023Aug 11 07:07 PM
JOG VIKRAMCHIEF FINANCIAL OFFICERAug 07Sale26.343,73398,327290Aug 11 07:07 PM
Worthington Gajus VincentPRESIDENT & CEOAug 06Sale26.536,000159,16344,188Aug 08 07:44 PM
Smith William MaxwellEVP, LEGAL AFFAIRS & GCJul 15Option Exercise3.393,00010,1723,290Jul 17 06:40 PM
Smith William MaxwellEVP, LEGAL AFFAIRS & GCJul 15Sale31.983,00095,940290Jul 17 06:40 PM
JOG VIKRAMCHIEF FINANCIAL OFFICERJul 07Option Exercise15.495,42784,0645,717Jul 09 06:36 PM
JOG VIKRAMCHIEF FINANCIAL OFFICERJul 07Sale30.615,427166,125290Jul 09 06:36 PM
Worthington Gajus VincentPRESIDENT & CEOJul 01Sale29.726,000178,32850,188Jul 03 06:16 PM
Smith William MaxwellEVP, LEGAL AFFAIRS & GCJun 16Option Exercise3.393,00010,1723,290Jun 18 08:25 PM
Smith William MaxwellEVP, LEGAL AFFAIRS & GCJun 16Sale27.643,00082,920290Jun 18 08:25 PM
JOG VIKRAMCHIEF FINANCIAL OFFICERJun 09Option Exercise15.493,95061,1864,240Jun 11 08:24 PM
JOG VIKRAMCHIEF FINANCIAL OFFICERJun 09Sale26.963,950106,492290Jun 11 08:24 PM
Worthington Gajus VincentPRESIDENT & CEOJun 02Sale26.556,000159,29156,188Jun 04 07:05 PM
Smith William MaxwellEVP, LEGAL AFFAIRS & GCMay 15Option Exercise3.393,00010,1723,000May 19 07:10 PM
Smith William MaxwellEVP, LEGAL AFFAIRS & GCMay 15Sale28.533,00085,5900May 19 07:10 PM
Worthington Gajus VincentPRESIDENT & CEOMay 08Sale32.146,000192,81562,188May 12 07:22 PM
Smith William MaxwellEVP, LEGAL AFFAIRS & GCApr 15Option Exercise3.393,00010,1723,000Apr 17 07:01 PM
Smith William MaxwellEVP, LEGAL AFFAIRS & GCApr 15Sale35.323,000105,9600Apr 17 07:01 PM
Worthington Gajus VincentPRESIDENT & CEOApr 09Option Exercise3.3933,029111,99533,029Apr 11 07:00 PM
JOG VIKRAMCHIEF FINANCIAL OFFICERApr 07Option Exercise15.295,09177,8285,091Apr 09 07:00 PM
JOG VIKRAMCHIEF FINANCIAL OFFICERApr 07Sale37.515,091190,9630Apr 09 07:00 PM
Worthington Gajus VincentPRESIDENT & CEOApr 01Sale45.126,000270,72235,159Apr 03 07:00 PM
Smith William MaxwellEVP, LEGAL AFFAIRS & GCMar 17Option Exercise2.933,0008,7863,000Mar 18 07:06 PM
Smith William MaxwellEVP, LEGAL AFFAIRS & GCMar 17Sale47.763,000143,2800Mar 18 07:06 PM
Walder Fredric TCHIEF OPERATING OFFICERMar 14Option Exercise8.372,76323,1352,763Mar 18 07:00 PM
Walder Fredric TCHIEF OPERATING OFFICERMar 14Sale46.652,763128,8940Mar 18 07:00 PM
JOG VIKRAMCHIEF FINANCIAL OFFICERMar 07Option Exercise16.273,95064,2523,950Mar 11 07:00 PM
JOG VIKRAMCHIEF FINANCIAL OFFICERMar 07Sale48.263,950190,6270Mar 11 07:00 PM
Worthington Gajus VincentPRESIDENT & CEOMar 03Sale45.666,000273,96041,159Mar 05 07:00 PM
Smith William MaxwellEVP, LEGAL AFFAIRS & GCFeb 18Option Exercise2.423,0007,2663,000Feb 20 07:00 PM
Smith William MaxwellEVP, LEGAL AFFAIRS & GCFeb 18Sale44.073,000132,2100Feb 20 07:00 PM
Walder Fredric TCHIEF OPERATING OFFICERFeb 14Option Exercise8.372,76323,1352,763Feb 19 07:00 PM
Walder Fredric TCHIEF OPERATING OFFICERFeb 14Sale43.512,763120,2180Feb 19 07:00 PM
JOG VIKRAMCHIEF FINANCIAL OFFICERFeb 11Option Exercise16.733,95066,0843,950Feb 13 07:00 PM
JOG VIKRAMCHIEF FINANCIAL OFFICERFeb 11Sale42.083,950166,2300Feb 13 07:00 PM
Worthington Gajus VincentPRESIDENT & CEOFeb 03Sale45.736,000274,36447,159Feb 05 07:00 PM
JONES ROBERT CEVP, RESEARCH & DEVELOPMENTJan 31Option Exercise4.453,50015,5613,500Feb 04 07:00 PM
JONES ROBERT CEVP, RESEARCH & DEVELOPMENTJan 31Sale43.283,500151,4800Feb 04 07:00 PM